# Mary O’Brien

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/mary-o-brien/

## Facts

| Field | Value |
| --- | --- |
| Citations | 27,027 |
| Field | Lung Cancer Treatments and Mutations |
| h-index | 64 |
| i10-index | 193 |
| OpenAlex ID | https://openalex.org/A5001503641 |
| ORCID iD | https://orcid.org/0000-0002-8557-8957 |
| Works | 462 |

## Researcher papers

- [Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer](https://scholariq.org/papers/pembrolizumab-versus-chemotherapy-for-pd-l1-positive-non-small-cell-lung-cancer/)

## Researcher topics

- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Cancer Treatment and Pharmacology](https://scholariq.org/topics/cancer-treatment-and-pharmacology/)
- [Occupational and environmental lung diseases](https://scholariq.org/topics/occupational-and-environmental-lung-diseases/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.